Thursday, August 18th, 2011

SYDNEY, AUSTRALIA - On Tuesday August 23rd, Australia’s leading private investment platform Wholesale Investor and AusBiotech in association with principal support partner PricewaterhouseCoopers, will host the Life Sciences Showcase 2011 in Sydney.

The Life Sciences Showcase will provide up to 200 high net worth and professional investors with the opportunity to gain direct access to 12 Private and ASX Listed companies in one afternoon.

With the recent share price success of companies such as Acrux, Mesoblast, ChemGenex and Bionomics there has been an increase in appetite for the biotech/healthcare 'space'. says Managing Director of Wholesale Investor Steve Torso "We are proud to be showcasing 12 of Australia’s most innovative and high growth Life Science companies to investors, fund managers and brokers. The event provides them with a rare opportunity to speak directly with the CEO, and gain information straight from the source.”

Special Guest Speaker - Acrux Limited (ASX:ACR) CFO, Jon Pilcher

Acrux in the last 2-and-a-half years has gone from being a hopeful Life Sciences at 0.46c to one of Australia's leading Biotech companies at $4 and a market cap of over $650mill. They are a great Australian success story and a reference for what is possible for Australian Life Science companies.

Acrux CFO Jon Pilcher, will provide insights into the global deal brokered for Axiron with Eli Lilly and the opportunities available for Australian Biotechs in the global markets.

Snapshot of Companies Presenting

Examples of the companies being showcased include:

Phylogica Limited (ASX:PYC) - A Life Sciences ASX Listed company which has recently announced agreements with large Pharmas Roche and AstraZeneca subsidiary MedImmune.

Bionomics Limited (ASX:BNO) - is a ASX Listed Biotech which has seen their share price grow by over 80% in 2011. The company has added an impressive list of investors to their register including Ausbil Dexia Limited, along with hitting key milestones in drug trials.

Mesynthes - Mesynthes is a soft-tissue reconstruction company using its proprietary Endoform technology to develop regenerative tissue substitutes for reconstructive surgery and wound care. In March 2011, the company secured a North American marketing and distribution agreement with a major healthcare multinational for their first Endoform based product.

These are just 3 of the 12 stories to be shared on the day!

Entry is free. Refreshments will be provided throughout the afternoon. Attending investors will also receive a free 12-month subscription to Wholesale Investor Magazine.

Life Sciences Showcase 2011 - Event Details

Date: Tuesday, 23rd of August
Time: 12.30pm to 4.30pm
Venue: NSW Trade and Investment, Level 47 MLC Building, Martin Place
Catering: Canapes will be served throughout the entire day.
Entry: FREE. Limited places, registration is essential.

To register for the Life Sciences Showcase, go to:

Presenting Companies:

Presenting companies include:

  • Bionomics Limited (ASX:BNO) 
  • Phylogica Limited (ASX:PYC)
  • Global Kinetics Corporation
  • Photonz Corporation
  • QBiotics Limited
  • Jubilent Health
  • Bioglobal Limited
  • Special Phage Holdings
  • Mesynthes
  • Xenexus Pharmaceuticals

The Life Sciences Showcase 2011 is proudly supported by;

PwC, GEON Communications, Thomson Reuters, Computershare, NSW Trade and Investment, Commercialisation Australia, Eureka Report, Edison Investment Research and Patersons Securities.

Firms and Media confirmed to be represented at the Life Sciences Showcase

Along with many private investors, below are some of the firms registered to attend the event;

PwC, Wade Investment Group, Macquarie Bank, Beconwood Securities, Biospecialties International, NSW Trade and Investment, Merger market, Patersons Securities, Septimus Capital Partners, Tane Nui Funds Management, Cochlear, AstraZeneca, Clime Asset management, CM Capital, Vitaco Health Australia, GBS Venture Partners, Bio-link Australia, Bioadvisory Group, Lemsec, Growth Equity Partners, Aboyne Investments, Computershare, Gilmore Capital, Inteq, IB Australian Bioscience Fund, Life Sciences Queensland, ANZ Bank, Westpac, Commercialisation Australia,, Thomson Reuters, PALL Life Sciences, AFG Venture Group, Janssen, Fortman Cline, Edison Investment Research, Pacific Union Capital, Frost & Sullivan, West Pharmaceutical Services, AusIndustry, Meat and Livestock Australia, Australia ZHEJIANG International Business Association, Austrade, Consulate General of Canada and Clearview.

Contact Profile

Wholesale Investor

Wholesale Investor is Australia's leading private investment platform showcasing Private, Pre-IPO and Life Sciences ASX Listed Opportunities to over 8,600 High Net Worth, Professional and International investors.
Steve Torso
P: Ph: 1300 597 595


Biotech, Medical Device, Pharmaceutical, Phylogica, Bionomics, Acrux




More Formats

View QR Code